Group 1 - The core viewpoint of the news highlights that Chao Yan Co., Ltd. has seen a stock price increase of 3.74% to 26.62 yuan, with a rolling PE ratio of 72.04, marking a new low in 39 days, and a total market capitalization of 11.402 billion yuan [1] - The average PE ratio for the medical device industry is 50.80, with a median of 36.71, positioning Chao Yan Co., Ltd. at the 99th rank within the industry [1] - As of the first quarter of 2025, 15 institutions hold shares in Chao Yan Co., Ltd., including 13 funds, 1 other entity, and 1 QFII, with a total holding of 681,500 shares valued at 0.18 billion yuan [1] Group 2 - Chao Yan Co., Ltd. specializes in the research, production, and sales of medical imaging equipment and industrial non-destructive testing equipment, with key products including industrial ultrasound, medical ultrasound, X-ray, and accessories [1] - The company has established a strong market presence and stable customer base, with its industrial ultrasound non-destructive testing products recognized as a Guangdong Province brand product [1] - In 2022, the company received the second prize of the National Defense Technology Invention Award from the Ministry of Industry and Information Technology for its project on "New Technology for High-Precision Non-Destructive Testing of Complex Large Components and Its Major Applications" [1] Group 3 - The latest performance report for the first quarter of 2025 shows that the company achieved an operating income of 98.4324 million yuan, a year-on-year increase of 28.69%, and a net profit of 39.322 million yuan, a year-on-year increase of 47.70%, with a gross profit margin of 73.83% [1]
超研股份收盘上涨3.74%，滚动市盈率72.04倍，总市值114.02亿元